Katritch- university of southern california dmfp for BPN-35269 - curia global, INC.

Active Awarded Last action

Contract number
75N95023F00001
Awardee
Awarding agency
Obligated
$2,451,019

Award facts

Contract value 70% obligated
  • $2,451,018.78 Current, with exercised options
  • $3,498,938.33 Potential, with all options
Completion date 52% complete
Current and potential, with all options
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Dockweiler, CA 90007, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00002 $992,331
Funding Only Action P00001 $365,643
Original award $1,093,045

About this award

The National Institute of Neurological Disorders and Stroke issued a delivery order to Curia Global Inc. on September 13, 2023, under the Drug Manufacturing and Formulation Program (DMFP) IDIQ with a ceiling value of $3,498,938.33.

The DMFP is an NIH parent IDIQ supporting contract development and manufacturing organization services for pharmaceutical research and development across the National Institutes of Health. Place of performance is Dockweiler, CA. The order extends through September 12, 2029, and is priced on a cost-plus-fixed-fee basis.

In FY2024, the order invoiced $482 thousand across 1.2 FTEs and 2,416 contractor hours, yielding a derived government-paid rate of $199.41 per hour. Curia Global self-performed all reported work with no subcontractors.

Quick answers

Who was awarded contract 75N95023F00001?

75N95023F00001 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 13, 2023.

How much is contract 75N95023F00001 worth?

The government has obligated $2,451,019 on 75N95023F00001. Its potential value, with all options, is $3,498,938.

Which agency awarded contract 75N95023F00001?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Is contract 75N95023F00001 an order under another contract?

Yes. 75N95023F00001 is a delivery order under HHSN271201500005I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).

Was contract 75N95023F00001 competed?

The extent of competition for 75N95023F00001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award